Specializes in
Myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, myelofibrosis, chronic myeloid leukemia, chronic myelomonocytic leukemia, systemic mastocytosis, hypereosinophilic syndrome
Appointments
- Gary C. Werths Building at Siteman Cancer Center4500 Forest Park AvenueFloor: 6St. Louis, MO 63108314-362-7216
Hospital Affiliations
This provider offers inpatient care at these hospitals.
- Barnes-Jewish Hospital
Experience
Board Certifications
- Internal Medicine
- Hematology
Academic Title(s)
Associate Professor, MedicineCo-Chief, Division of Hematology
Research Interests
Myeloproliferative neoplasms, including the application of single cell mass cytometry to interrogate operturbed signaling networks in MPNs, and the application of next generation sequencing technologies to delineate genomic complexity and clonal evolution in MPNs.
Publications & Research
View research profile »Education
1996 Harvard University, Cambridge, MA
2004 Cancer Biology, Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL
2006 Stanford University School of Medicine, Stanford, CA
2010 Hematology/Oncology, Stanford University School of Medicine, Stanford, CA
- Harmonic Discovery
- Equity: Yes
- Reporting Date: 05/01/2025
- Phoenix Molecular Designs
- Equity: Yes
- Reporting Date: 05/01/2025
Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.
Is this your profile? Request an edit »